Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P83
Within normal range
vs 2Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 7.62% |
| 2024 | 0.79% |
| 2023 | 3.46% |
| 2022 | -34.30% |
| 2021 | 21.52% |
| 2020 | -507.54% |
| 2019 | 0.00% |